KAKEN PHARMACEUTICAL CO., LTD.

Transcripts Kaken Pharmaceutical Co., Ltd.

Equities

4521

JP3207000005

Market Closed - Japan Exchange Other stock markets 11:30:00 26/06/2024 am IST			5-day change	1st Jan Change
3,824 ^JPY	+0.63%		+0.79%	+13.98%

2023	Kaken Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for Fiscal Year Ending March 31, 2024	CI
2023	Kaken Pharmaceutical Co., Ltd.(TSE:4521) dropped from FTSE All-World Index	CI

Transcripts

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Kaken Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	25/22/25	CI
Kaken Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022	15/22/15	CI
Kaken Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months and Full Year Ending March 31, 2021	03/20/03	CI
Kaken Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 2020 and Full Year Ending March 31, 2021	09/20/09	CI
Kaken Pharmaceutical Co., Ltd. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2018; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2019; Provides Dividend Guidance for the Year Ending March 31, 2019	13/19/13	CI
Kaken Pharmaceutical Co. Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings and Dividend Guidance for the Six Months and Full Year of Fiscal Year 2017	17/16/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer